Literature DB >> 30472995

A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous Cell Skin Cancer.

Wei Wang1, Eric Jorgenson2, Nilah M Ioannidis3, Maryam M Asgari4, Alice S Whittemore5.   

Abstract

Cutaneous squamous cell cancers (cSCCs) present an under-recognized health issue among non-Hispanic whites, one that is likely to increase as populations age. cSCC risks vary considerably among non-Hispanic whites, and this heterogeneity indicates the need for risk-stratified screening strategies that are guided by patients' personal characteristics and clinical histories. Here we describe cSCCscore, a prediction tool that uses patients' covariates and clinical histories to assign them personal probabilities of developing cSCCs within 3 years after risk assessment. cSCCscore uses a statistical model for the occurrence and timing of a patient's cSCCs, whose parameters we estimated using cohort data from 66,995 patients in the Kaiser Permanente Northern California healthcare system. We found that patients' covariates and histories explained approximately 75% of their interpersonal cSCC risk variation. Using cross-validated performance measures, we also found cSCCscore's predictions to be moderately well calibrated to the patients' observed cSCC incidence. Moreover, cSCCscore discriminated well between patients who subsequently did and did not develop a new primary cSCC within 3 years after risk assignment, with area under the receiver operating characteristic curve of approximately 85%. Thus, cSCCscore can facilitate more informed management of non-Hispanic white patients at cSCC risk. cSCCscore's predictions are available at https://researchapps.github.io/cSCCscore/.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30472995     DOI: 10.1016/j.jid.2018.03.1528

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

Review 1.  Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?

Authors:  M R Roberts; M M Asgari; A E Toland
Journal:  Br J Dermatol       Date:  2019-07-07       Impact factor: 9.302

2.  Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.

Authors:  Jeffrey F Scott; Kevin R Brough; Konstantin V Grigoryan; John G Muzic; Grace Y Kim; Rosalynn R Z Conic; Sheena T Hill; Jerry D Brewer; Christian L Baum; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Shahrukh K Hashmi; Hillard M Lazarus; Jeremy S Bordeaux; Cheryl L Thompson; Meg R Gerstenblith; Julia S Lehman
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

3.  Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.

Authors:  S Tokez; M Alblas; T Nijsten; L M Pardo; M Wakkee
Journal:  Br J Dermatol       Date:  2020-02-26       Impact factor: 9.302

4.  Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.

Authors:  Y Kim; E Jorgenson; M M Asgari
Journal:  Br J Dermatol       Date:  2020-05-10       Impact factor: 9.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.